SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-24-004651
Filing Date
2024-08-09
Accepted
2024-08-09 16:45:25
Documents
61
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q edsa20240630_10q.htm   iXBRL 10-Q 861779
2 EXHIBIT 31.1 ex_706693.htm EX-31.1 12228
3 EXHIBIT 31.2 ex_706694.htm EX-31.2 12144
4 EXHIBIT 32.1 ex_706695.htm EX-32.1 5514
5 EXHIBIT 32.2 ex_706696.htm EX-32.2 5352
  Complete submission text file 0001171843-24-004651.txt   4607303

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA edsa-20240630.xsd EX-101.SCH 48087
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20240630_def.xml EX-101.DEF 303572
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20240630_lab.xml EX-101.LAB 301817
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20240630_pre.xml EX-101.PRE 331717
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edsa-20240630_cal.xml EX-101.CAL 32585
64 EXTRACTED XBRL INSTANCE DOCUMENT edsa20240630_10q_htm.xml XML 662977
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37619 | Film No.: 241193487
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)